4basebio (LON:4BB) Shares Down 2% - Here's What Happened

4basebio PLC (LON:4BB) saw its shares decline by 2% during midday trading on Wednesday. The stock price dropped as low as GBX 1,200 ($15.31) and was last seen at the same price of GBX 1,200 ($15.31). In total, about 3,555 shares changed hands, marking a 19% decrease from the typical trading volume of 4,376 shares. The previous closing price was GBX 1,225 ($15.63).

4basebio Trading Down 2.0 %

The current market capitalization of the company is £153.72 million, with a price-to-earnings (P/E) ratio of -1,538.46 and a beta value of 1.09. The company's financial ratios indicate a debt-to-equity ratio of 201.47, a quick ratio of 3.52, and a current ratio of 2.73. The stock’s fifty-day moving average stands at GBX 1,301.31, while the two-hundred-day moving average is GBX 1,412.

Insider Activity

In recent news regarding 4basebio, insider Heikki Lanckriet purchased 46,500 shares of the company on November 15th. This transaction was completed at an average price of GBX 1,325 ($16.90) per share, accumulating a total investment of £616,125 ($785,973.98). It is noteworthy that insiders hold 68.44% of the company’s stock.

About 4basebio

4basebio PLC is engaged in various aspects of biotechnology, including the research, development, manufacturing, and marketing of synthetic DNA and RNA products, as well as targeted non-viral vector solutions across the globe, including the United States and Europe. The company also provides manufacturing services for AVV and Lentivirus, which are critical in the sectors of gene therapy and vaccine development.

stocks, market, investment